Navigation Links
Dr. Reddy's To Launch 'Polypill' For Treating Heart Disease

Indian pharma major Dr. Reddy's Laboratories will launch a first-of-its-kind pill to tackle heart diseases in the second half of 2007, it was announced Thursday. //

The company has teamed up with researchers at University of Auckland, New Zealand, for trials of the groundbreaking 'polypill' that combines four medicines including aspirin and statin, commonly used to treat heart ailments.

India records nearly 2.8 million deaths a year due to cardio-vascular diseases.

'Trials in India are underway. We are conducting trials on 220 patients and after testing on 440 more cases, the product will be launched in the Indian market,' said Satish Reddy, managing director of Dr. Reddy's Lab.

'We have already received the necessary approval from the government for conducting the trails. We hope the product will be available to masses in the second quarter of 2007,' he told reporters at the New Zealand High Commission here.

'This is first-of-its-kind drug in the world to tackle heart problem and will open newer vistas to handle such ailments,' Reddy told IANS, adding it will cost Rs.100 for 30 tablets.

New Zealand's High Commissioner to India Graeme Waters said: 'This project holds open the possibility of revolutionising an important aspect of healthcare in both developing and developed countries.'

The new drug will be cheaper to administer and more effective in preventing strokes and heart attacks, said Anthony Rodgers, a researcher at Auckland University.

The trial aims to confirm that the polypill is effective in lowering cholesterol and blood pressure - known causes of heart attacks and strokes.

The Health Research Council of New Zealand invested NZ$350,000 to support the overall co-ordination of the trial and recruitment in New Zealand. Dr. Reddy's will invest NZ$ 7.5 million in developing the polypill and providing supplies for clinical trials globally.

Source-
'"/>




Page: 1 2

Related medicine news :

1. AAI Pharma Files Lawsuit Against Dr. Reddys Laboratories
2. Dr Reddys Launches Generic Version Of Mercks Proscar Tablets
3. Dr. Reddys To Invest $100 Mn In Andhra
4. Dr Reddys Eyeing for Generics Arm of Merck
5. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
6. Nutrient Profiling System Launched By Food Officials in UK
7. New Oat And Soy-Based Fat Replacer Launched
8. Launch Of India’s First Virology Course At Pun
9. Race Based Genome Project Launched By Mexico
10. Bird flu In Indonesia: Government To Launch ‘Village Preparedness’ Schee
11. Action Plan Against Drug Deaths Launched
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Reddy Launch Polypill For Treating Heart Disease

(Date:8/3/2015)... Miami, Florida (PRWEB) , ... August 03, 2015 , ... ... neuropathy pain accompanied by tissue injury caused by diabetes after many years of suffering ... work many times, and he didn’t want to ask for extra time off or ...
(Date:8/3/2015)... ... ... The American Institute of Architects (AIA) and ... a wide range of initiatives ranging from code development and compliance to sustainability ... membership, consisting of practicing design professionals, code officials, and the building industry representatives, ...
(Date:8/2/2015)... ... ... A new Phase I research study is looking at a vaccine that hopes ... G. Lucas, M.D. , chief of the division of pediatric hematology/oncology and stem cell ... Hospital and in the UofL Department of Pediatrics . Patients are currently ...
(Date:8/1/2015)... ... August 02, 2015 , ... AlignLife Office Coordinator Heather Pugh ... of care for patients at this natural health care center in Winamac. , "Oftentimes ... Heal said. "Heather's role is vital to our approach because we want to focus ...
(Date:8/1/2015)... ... August 01, 2015 , ... The condition where veins are ... and women often causing pain and discomfort. Those who spend a lot of time ... Northeast Houston Vein Center is doing what it can to create awareness and provide ...
Breaking Medicine News(10 mins):Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 3Health News:Architects, International Code Council Ink Five-Year Collaborative Agreement 2Health News:Architects, International Code Council Ink Five-Year Collaborative Agreement 3Health News:UofL Physicians Conducting Vaccine Trial for Children with Relapsed Tumors at Kosair Children’s Hospital 2Health News:New Patient Advocate Enhances Natural Health Care 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 3
... ... expensive education in the thriving nursing industry. , ... Seattle, Washington (PRWEB) July 30, 2009 -- According to ... and online nursing degrees are becoming a popular and effective way to capitalize on ...
... with the autoimmune disease systemic lupus erythematosus (SLE) have ... in their immune responses and treatment with immunosuppressive drugs. ... in immunocompromised patients, it is recommended that patients with ... do not increase disease activity. Both antibody and cell-mediated ...
... , , TAMPA, Fla., July 29 ... great excitement and enthusiasm that Tampa Bay Radiation Oncology announces the grand ... 2009. Located at 12206 Bruce B Downs Blvd, near the VA ... to residents in the Tampa Bay area communities. , , ...
... , , ... a beautiful place for patients to relax, it is an award ... Agnes and Morland Hamilton Healing Conservatory at Aurora St. Luke,s Medical ... , , (Logo: http://www.newscom.com/cgi-bin/prnh/20090303/CG78204LOGO-b ) , ...
... OF PRUSSIA, Pa., July 29 Health Market Science ... product for the master data management market. The ... including life sciences, payer, pharmacy benefits management and pharmacy. ... for complete customer master data management. , ...
... , ADDISON, Texas, July 29, ULURU Inc. ... and best clinical practice will be demonstrated in a hands-on Wound Care ... August 2. In addition, clinical evidence on the treatment of wounds ... meeting. , , Renaat Van den Hooff, President and ...
Cached Medicine News:Health News:All Nursing Schools Sheds Light on Online Nursing Degree Opportunities in a Rough Economy 2Health News:Immune responses to flu vaccine are diminished in lupus patients 2Health News:Aurora St. Luke's Healing Garden Earns LEED Certification 2Health News:Health Market Science Unveils CompleteView, the Most Comprehensive Master Data Management (MDM) Solution Available in the Healthcare Market 2Health News:Health Market Science Unveils CompleteView, the Most Comprehensive Master Data Management (MDM) Solution Available in the Healthcare Market 3Health News:ULURU Inc. to Present Altrazeal(TM) Clinical Evidence at the American Podiatric Medical Association (APMA) Annual Scientific Meeting in Toronto, Canada 2Health News:ULURU Inc. to Present Altrazeal(TM) Clinical Evidence at the American Podiatric Medical Association (APMA) Annual Scientific Meeting in Toronto, Canada 3
(Date:7/31/2015)... July 31, 2015 Magnaquest, ... video, data and cloud computing operators has signed ... pharma giant for Internet of Things (IoT) related ... offered on subscription model.      (Logo: ... is striving for business innovations to make healthcare ...
(Date:7/30/2015)... -- ResMed Inc. (NYSE: RMD ) today announced results ... the quarter was $453.1 million, a 9 percent increase ... 17 percent increase on a constant currency basis).  Net ... June 30, 2014.  Diluted earnings per share for the ... 30, 2014.  The results for the ...
(Date:7/30/2015)... BOTHELL, Wash. and VANCOUVER ... OGXI ) announced today that it will report ... 13, 2015. Company management will host a conference call ... provide an overview of financial results, clinical development programs ... access the webcast, log on to the Investor Relations ...
Breaking Medicine Technology:Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 3ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 4ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 5ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 6ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 7ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 8ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 9ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 10ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 11ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 12ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 13ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 14ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 15ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 16
... a privately held personalized medicine company focused on cancer, ... C (GCC) Lymph Nodes (LN) Classification as a Prognostic ... Pooled Analysis" at the 2012 American Society of Clinical ... 21, 2012.  The data from the paper demonstrate the ...
... 23, 2012 InspireMD, Inc. (OTC BB: NSPR) (the ... the development and commercialization of its proprietary stent platform ... today announced its business objectives for 2012 and reviewed ... the Company,s proprietary MicroNet™ platform technology. ...
Cached Medicine Technology:Signal Genetics Announces Publication of Meta-Analysis of its Colon Cancer Test-Previstage™ GCC Confirming Prognostic Capabilities in Patients with Colon Cancer 2InspireMD Provides Corporate Update, Plans for 2012 2InspireMD Provides Corporate Update, Plans for 2012 3InspireMD Provides Corporate Update, Plans for 2012 4InspireMD Provides Corporate Update, Plans for 2012 5InspireMD Provides Corporate Update, Plans for 2012 6
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: